Endo Sponge Vacuum Therapy for Anastomotic Leaks

An endo sponge is a small, open-pored polyurethane foam device placed endoscopically inside a wound cavity to promote healing through continuous suction. It is the core component of endoscopic vacuum therapy (EVT), a technique used primarily to treat leaks and perforations in the gastrointestinal tract, from the esophagus down to the rectum. Originally adapted from the negative-pressure wound therapy long used on external surgical wounds, the endo sponge has become one of the more significant developments in managing post-surgical gut leaks over the past two decades, with clinical success rates frequently reported above 80 percent across a range of indications.

How the Endo Sponge Works

The endo sponge operates on the same principle as vacuum-assisted wound closure on the skin, but miniaturized and adapted for internal use. A cylinder of open-pored polyurethane foam is connected to a drainage tube, introduced through a standard endoscope, and positioned inside the wound cavity or against the defect. Once connected to a low-pressure suction device, the sponge continuously drains fluid, pus, and wound debris away from the area. That constant negative pressure does several things at once: it pulls the wound edges closer together, removes bacteria-laden fluid that would otherwise pool and cause infection, and physically stimulates the tissue to grow new blood vessels and granulation tissue.

Animal studies have helped quantify the vascular effects. In a porcine model of esophageal ischemia, tissue oxygenation dropped from about 65 percent to roughly 45 percent when blood flow was restricted. After vacuum therapy at negative 125 mmHg was applied, oxygenation rebounded to about 62 percent within an hour and held steady, nearly matching the pre-ischemia baseline.¹ The same study found that lower suction pressures (negative 40 mmHg) produced smaller, non-significant improvements, while very high pressures (negative 200 mmHg) restored oxygenation but caused tissue swelling. This suggests a therapeutic sweet spot around negative 125 mmHg, which is the pressure most clinical protocols use.

Beyond oxygenation, the sponge promotes new blood vessel formation. Research has shown that negative pressure at this level can roughly double the density of blood vessels in the wound bed compared to pre-treatment levels.² Granulation tissue, the reddish, bumpy tissue that fills in healing wounds, grows in response to the micro-scale stretching of cells the sponge creates. Whether the vacuum actually clears bacteria from the wound bed remains an open question; studies on antimicrobial effects have produced conflicting results, so that particular benefit has not been firmly established.³

What the Procedure Looks Like

Placing an endo sponge is an endoscopic procedure, meaning it is done through a flexible camera passed through the mouth (for upper GI problems) or the anus (for lower GI problems), with no external incisions. The clinician first examines and rinses the abscess cavity with saline, then estimates its size. The sponge is trimmed to fit, sometimes with multiple sponges placed if the cavity is large. It is delivered through a plastic overtube that is slid over the endoscope and into the deepest part of the cavity. Once the scope is pulled back, the sponge is pushed through the tube using a probe, and the tube is withdrawn, leaving the sponge seated against the wound walls.⁴

No clips or stitches are needed to hold the sponge in place. The suction itself keeps it anchored. Once positioned, the drainage tube runs out of the body and connects to a portable, low-vacuum suction bottle that the patient can carry. Every three to four days the sponge must be exchanged. Leaving it longer risks the wound tissue growing into the foam’s pores, which makes removal painful and can cause bleeding. Before each removal, saline or lidocaine is flushed into the sponge to loosen it from the surrounding tissue. With each exchange, the clinician trims the replacement sponge a bit smaller to match the shrinking cavity, and the process repeats until the wound has closed. Closure is confirmed by endoscopy and contrast imaging.⁵

For many patients with colorectal leaks, sponge exchanges can be performed on an outpatient basis, avoiding prolonged hospitalization. In one study, about half of patients were managed as outpatients, which cut the median hospital stay by 15 days and maintained a 98 percent treatment success rate.⁶ Younger patients were more likely to be candidates for this approach.

Treating Colorectal Anastomotic Leaks

The most established use of the endo sponge is managing anastomotic leaks after rectal cancer surgery. When two sections of bowel are reconnected (an anastomosis), the join sometimes fails to heal properly, allowing intestinal contents to escape into the surrounding tissue. This is a serious complication that historically required additional surgery, often resulting in a permanent or long-term stoma (a bag worn on the abdomen for waste collection). The endo sponge offered a less invasive alternative.

A systematic review and meta-analysis pooling data from 17 studies and 384 patients found a technical success rate (meaning the sponge could be placed correctly) of essentially 100 percent, and a clinical success rate of about 85 percent, meaning the leak healed without the need for further major surgery.⁷ A separate systematic review of 266 patients reported a median treatment failure rate of about 12 percent, and found that starting endo-sponge therapy early significantly improved outcomes, while patients who had received radiation therapy before surgery fared worse.⁸

One important metric for patients is whether they end up needing a stoma. In that same review, about half of diverting stomas (temporary stomas created to protect the healing anastomosis) were successfully closed after endo-sponge treatment.⁹ However, one population-based study found that patients treated with endo-sponge had a higher rate of still having a stoma one year after surgery compared to patients treated with other anastomosis-preserving methods (about 34 percent versus 14 percent).¹⁰ This likely reflects the fact that endo-sponge therapy tends to be used for more severe or complicated leaks, so the comparison is not apples-to-apples. The patients selected for endo-sponge treatment often had larger cavities or more sepsis than those managed with simpler approaches.

Upper GI Uses, From the Esophagus to the Stomach

The endo sponge has found a growing role in the upper gastrointestinal tract, particularly for esophageal perforations, post-esophagectomy leaks, and leaks after bariatric (weight loss) surgery. These are some of the most dangerous complications in GI surgery because the chest cavity sits right next to the esophagus, and a leak can rapidly cause life-threatening infection.

For esophageal defects, multicenter data show defect closure rates in the range of 80 to 90 percent when vacuum therapy is applied early and the perforation is contained.¹¹ One early prospective study of 10 patients with esophageal perforations and leaks achieved successful closure in 7 of 10 cases without severe complications.¹² Another series treating intrathoracic esophageal leaks after esophagectomy reported healing in all six patients treated, with no local complications and no need for reoperation.¹³

After bariatric surgery, gastric leaks (most commonly at the staple line following sleeve gastrectomy) are a feared complication. In one series of nine patients, all of whom had confirmed leaks, vacuum therapy resolved every leak, though treatment took an average of 50 days and required an average of about 10 sponge exchange procedures per patient.¹⁴ A larger study over 10 years found a 100 percent success rate for vacuum therapy in bariatric leak patients, both when used as the first treatment and when used after a failed surgical revision.¹⁵ Detecting leaks early and starting vacuum therapy promptly shortened both treatment duration and hospital stay. A separate study of 20 bariatric leak patients reported a 90 percent healing rate and noted that septic infection was typically brought under control within two days of starting therapy.¹⁶

Endo Sponge Versus Stents

Before vacuum therapy became widely available, the main endoscopic option for managing GI leaks was placing a self-expanding metal stent across the defect to cover it and let it heal underneath. Several head-to-head comparisons have now been published, and the endo sponge generally comes out ahead on healing rates and complication rates, though the picture on cost and hospital stay is more mixed.

In one comparative study of post-surgical gastroesophageal leaks, all seven patients treated with vacuum therapy healed successfully, compared to seven out of eleven (about 64 percent) in the stent group. The complication rate was zero in the vacuum group versus 55 percent in the stent group, a statistically significant difference. Median time to clinical success was also shorter with vacuum therapy: about 20 days versus 27 days.¹⁷ A larger comparison after esophagectomy found a similar pattern: vacuum therapy achieved roughly 93 percent success versus 63 percent for stents, though mortality and length of hospital stay were similar between groups.¹⁸

The cost question is less flattering for the endo sponge. Because the sponge needs to be exchanged every few days, each requiring an endoscopic procedure, the total number of interventions can be high. One economic analysis found that total costs for vacuum therapy after esophagectomy were about 37 percent higher than for stent treatment, largely because of longer overall hospital stays and more procedures.¹⁹ This trade-off matters in practice: vacuum therapy tends to work better, but the process is more labor-intensive and expensive, at least in the upper GI tract where outpatient exchanges are harder to arrange.

Complications and Safety Profile

Endo sponge therapy is generally well tolerated, but it is not risk-free. The most commonly reported local complications are new abscess formation, fistula development (an abnormal connection between the bowel and another structure), and bleeding. In a national prospective registry of patients treated with endo sponge for esophageal anastomotic leaks, new abscesses developed in about 4 percent of patients, fistulas in about 9 percent, and bleeding in about 6 percent. In patients treated for esophageal perforations rather than surgical leaks, the new abscess rate was higher at about 21 percent.²⁰

Rare but serious complications have been documented. In one early pilot study, two patients developed esophageal narrowing (stenosis) that required dilation after treatment. In one of those patients, dilation triggered a fatal hemorrhage from an abnormal connection between the aorta and the surgical site.²¹ Events like this are extremely uncommon but underscore that the therapy is used in patients who are already critically ill with complex wound-healing problems near major blood vessels.

Minor discomfort during sponge exchanges is expected, especially in the lower GI tract. Flushing saline or lidocaine before removal helps, but patients describe the exchanges as unpleasant even if tolerable. The tissue ingrowth that occurs if sponges are left in place too long is the main driver of exchange-related pain, which is why strict adherence to the three-to-four-day exchange schedule matters.

When Endo Sponge Therapy Fails

Despite high success rates, roughly 10 to 20 percent of patients do not heal with vacuum therapy alone. Identifying who is at higher risk of failure helps clinicians decide whether to start with endo sponge therapy or go straight to surgery.

A multicenter study of upper GI leaks found that patients who had received pre-operative chemotherapy or radiation (neoadjuvant treatment) and those treated with the sponge placed inside the gut lumen rather than inside the wound cavity itself were significantly more likely to fail.²² For rectal anastomotic leaks specifically, a systematic review identified pre-operative radiotherapy, lack of a diverting stoma, male sex, and the presence of other complications as risk factors for failure.²³ The radiotherapy finding is consistent across both upper and lower GI data, which makes biological sense: radiation damages the microvasculature of tissue, impairing exactly the kind of new blood vessel growth that vacuum therapy relies on.

Timing also matters. As noted earlier, earlier detection and earlier initiation of vacuum therapy consistently produce better outcomes. Patients who arrive weeks or months after the initial leak, often transferred from other hospitals, tend to need more sponge exchanges and longer treatment courses. One bariatric leak series in which patients were admitted from outside hospitals an average of 61 days after surgery still achieved full healing, but required about 10 procedures per patient over 50 days of treatment.²⁴

Use in Children

Adapting the endo sponge for pediatric patients presents obvious challenges: smaller anatomy, fewer off-the-shelf device sizes, and limited published experience. Still, a growing body of case series suggests the technique works well in children. A review of 17 pediatric esophageal perforations treated with endoscopic vacuum therapy reported an 88 percent success rate at sealing the defect, with no technical failures during placement. Success rates were similar whether the perforation occurred after surgery or after another endoscopic procedure.²⁵

Because commercially available sponges are sized for adults, pediatric teams have improvised. One group described a “Replogle modified” technique using a repurposed nasogastric suction catheter as the drainage tube, allowing the system to fit smaller esophageal diameters.²⁶ Pediatric use remains largely a case-by-case decision at specialized centers, but the early safety and effectiveness data are encouraging enough that it is increasingly considered when a child has an esophageal or anastomotic defect that would otherwise require open surgery.

Open-Pore Film Drainage, a Newer Alternative to the Sponge

The traditional polyurethane foam sponge is not the only material that can deliver negative-pressure therapy inside the gut. A newer variant uses a thin, open-pored film rather than a thick foam block. This film-based system distributes suction evenly but, because its surface is smooth rather than porous, tissue does not grow into it the way it grows into a sponge. That means it can stay in place longer, up to about eight days between exchanges, roughly halving the number of endoscopic procedures a patient needs.²⁷

The film’s low-adhesion surface also makes it safer to place near delicate structures. With a foam sponge, positioning it directly against the lung lining (pleura) or thin-walled intestine carries a risk of erosion. The film can be used in those situations with less concern. It still stimulates granulation tissue through the suction effect, just without the aggressive mechanical grip of the foam. In practice, many centers now use the two materials in combination, starting with the sponge for its stronger debridement and tissue-stimulation effects, then switching to the film as the cavity shrinks and tissue ingrowth becomes the primary risk.

Instillation Therapy

Another refinement involves periodically flushing antiseptic or saline solution through the sponge while it remains in place, a technique sometimes called instillation EVT (iEVT). The idea is to enhance bacterial clearance, which, as noted earlier, standard vacuum therapy alone does not reliably achieve. In a small series of six patients with colorectal defects and perianal complications, instillation therapy led to reductions in pus output and cavity size confirmed on imaging, with an average treatment duration of about 21 days over roughly six sessions.²⁸ The evidence is still thin, but the concept has attracted interest precisely because infection control is the weakest link in the endo sponge’s otherwise strong mechanistic profile.

Colorectal Leaks Treated Without a Stoma

For patients undergoing rectal cancer surgery, one of the most anxiety-provoking questions is whether they will end up with a stoma. Standard practice often involves creating a temporary diverting stoma at the time of surgery to protect the new bowel connection, with a plan to reverse it once healing is confirmed. When a leak occurs, the question becomes whether the stoma can ever be reversed, or whether it becomes permanent.

Some centers have explored using the endo sponge in patients who never had a diverting stoma created in the first place. Case reports describe successful management of anastomotic leaks with endo-sponge therapy alone, avoiding both revision surgery and stoma creation.²⁹ However, systematic review data have identified the absence of a diverting stoma as a risk factor for endo-sponge treatment failure, so this remains a carefully selected approach rather than a routine one.³⁰ For the right patient, though, it represents the possibility of recovering from a serious complication without ever needing an external bag.

Early data comparing endoscopic management (including but not limited to endo sponge) versus reoperation for rectal anastomotic leaks found that the endoscopic approach resulted in fewer patients needing a new stoma (54 percent versus 86 percent) and a higher proportion of patients living stoma-free at the end of follow-up (77 percent versus 57 percent).³¹ These numbers come from a small study mixing several endoscopic techniques, so they should be taken as directional rather than definitive, but they reflect the overall trend in the field toward minimally invasive leak management.